Copyright
©2011 Baishideng Publishing Group Co.
World J Gastroenterol. Jul 21, 2011; 17(27): 3242-3247
Published online Jul 21, 2011. doi: 10.3748/wjg.v17.i27.3242
Published online Jul 21, 2011. doi: 10.3748/wjg.v17.i27.3242
Group | n | Clinical recovery | Significant improvement | Improvement | Invalidation | Total effective rates | |
PP | Treatment group | ||||||
Patients with successful H. pylori eradication | 72 | 11 (15.3) | 21 (29.1) | 30 (41.7) | 10 (13.9) | 32 (44.4)a | |
Patients receiving H. pylori eradication therapy | 84 | 12 (14.3) | 24 (28.6) | 33 (39.3) | 15 (17.8) | 36 (42.9)a | |
Placebo group | 89 | 3 (3.4) | 16 (18.0) | 34 (38.2) | 36 (40.4) | 19 (21.4) | |
ITT | Treatment group | 98 | 12 (12.2) | 24 (24.5) | 33 (33.7) | 29 (29.6) | 36 (36.7)a |
Placebo group | 97 | 3 (3.1) | 16 (16.5) | 34 (35.1) | 44 (45.4) | 19 (19.6) |
-
Citation: Lan L, Yu J, Chen YL, Zhong YL, Zhang H, Jia CH, Yuan Y, Liu BW. Symptom-based tendencies of
Helicobacter pylori eradication in patients with functional dyspepsia. World J Gastroenterol 2011; 17(27): 3242-3247 - URL: https://www.wjgnet.com/1007-9327/full/v17/i27/3242.htm
- DOI: https://dx.doi.org/10.3748/wjg.v17.i27.3242